My SciELO
Services on Demand
Journal
Article
Indicators
- Cited by SciELO
- Access statistics
Related links
- Cited by Google
- Similars in SciELO
- Similars in Google
Share
Archivos de la Sociedad Española de Oftalmología
Print version ISSN 0365-6691
Abstract
CASTRO-REBOLLO, M.; MONTES-MOLLON, M.A.; PEREZ-RICO, C. and TEUS, M.A.. Effectiveness of topical bevacizumab in bilateral primary lipid keratopathy. Arch Soc Esp Oftalmol [online]. 2011, vol.86, n.11, pp.374-376. ISSN 0365-6691.
Case report: A 75-year-old man with bilateral idiopathic lipid keratopathy underwent a penetrating keratoplasty in the left eye. One month later, there was deep corneal neovascularisation extending across the bed and the graft-host interface, with a whitish opacity surrounding the vessels. Topical bevacizumab (25mg/mL) was administered 4 times daily for 2 months with partial regression of corneal neovascularization. Discussion: Topical bevacizumab may be useful in preventing a recurrence of lipid deposition after penetrating keratoplasty in patients with bilateral primary lipid keratopathy, although its long-term efficacy needs to be assessed.
Keywords : Bilateral primary lipid keratopathy; Topical bevacizumab; Corneal neovascularisation.